Skip to content

Pharminent

cropped-ChatGPT-Image-Jun-22-2026-05_46_48-PM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Policy / Pricing
  • Decoding Medicare Advantage Coding Intensity
  • Policy / Pricing

Decoding Medicare Advantage Coding Intensity

KFF Medicare

Federal payments to Medicare Advantage plans, and adjustments for health status, have come under increased scrutiny.

Read full story

pharminent July 1, 2026 (Last updated: July 2, 2026)

KFF Medicare

Federal payments to Medicare Advantage plans, and adjustments for health status, have come under increased scrutiny.

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: Ipsen to buy Swiss biotech Memo Therapeutics in potential $800M deal
Next: Ipsen Acquires Memo Therapeutics for Up to €700M in Second Deal in Three Days

Related Stories

  • Policy / Pricing

UK partners with Eli Lilly on obesity plan

pharminent June 29, 2026
  • Policy / Pricing

EFPIA report adds to pressures on EU drug pricing policy

pharminent June 24, 2026
  • Policy / Pricing

US launches probe of German ‘underpayment’ for medicines

pharminent June 19, 2026

You May Have Missed

  • News

Biogen Bets on Tau at AAIC: Diranersen Phase 2 CELIA Data

pharminent July 2, 2026
  • Manufacturing

FDA Selects Seven for PreCheck Pilot to Advance Drug Manufacturing

pharminent July 1, 2026
sample_feature_2026-06-23
  • News

Ipsen Acquires Memo Therapeutics for Up to €700M in Second Deal in Three Days

pharminent July 1, 2026
  • Policy / Pricing

Decoding Medicare Advantage Coding Intensity

pharminent July 1, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.